Johnson Matthey agrees £550m deal to sell business unit

The unit has manufacturing sites in the US, Mexico, and Australia.

August Graham
Wednesday 20 March 2024 11:22 GMT
Johnson Matthey’s office in London. (Philip Toscano/PA)
Johnson Matthey’s office in London. (Philip Toscano/PA) (PA Archive)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Johnson Matthey has agreed to sell its medical device components (MDC) unit in a half-billion pound deal which completes a plan to slim down parts of its business that was announced two years ago.

The chemicals and technologies company said on Wednesday that private equity company Montagu would buy the unit, which has factories in three countries, for 700 million US dollars (£550 million).

The unit produces components that it sells to the manufacturers of medical devices.

Its chief executive Don Freeman said: “We are delighted to be partnering with Montagu in the next phase of MDC’s development.

“They bring a significant amount of expertise in healthcare and in particular IP-led (intellectual property) medical devices, and they share our ambitions for the business over the coming years, both organically and through M&A (mergers and acquisitions).”

MDC runs manufacturing sites in the US, Mexico, and Australia.

Montagu was formed out of Midlands Bank – now HSBC – around half a century ago. It has assets of around 11 billion euro (£9.4 million).

It also owns Janes, a defence information company, funeral provider Dignity, Quorn-maker Marlow Foods, the University of Law, and many others.

Montagu partner Adrien Sassi said: “The carve-out of MDC aligns strongly with Montagu’s approach.

“MDC has rare and hard-to-replicate capabilities that enable it to handle the most complex and demanding precision-engineered components at scale.

“With support from Johnson Matthey, Don and his team have positioned the business to capitalise on the fast growth of its underlying markets and blue-chip OEM (original equipment manufacturer) customers.

“We look forward to supporting their ambitious expansion plans.”

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in